Launch of New Drug Lifted Ascendis Pharma A/S (ASND) in Q1
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Ascendis Pharma A/S (ASND)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,300,000 | $2,679,592 | -15% | 0.14% | |
| 2. | BIT Capital GmbH Jan Beckers | 0 | $0 | 0% | |
| 3. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,479,259 | $853,997,354 | 4.16% | |
| 2. | 1,877,917 | $292,692,144 | 0.1% | |
| 3. | 585,581 | $91,268,654 | 0.01% | |
| 4. | 517,154 | $80,603,624 | 0% | |
| 5. | 343,390 | $53,520,765 | 0.05% |
News See All
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to Ascendis Pharma First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Growth Stocks to Buy According to Billionaires
The stock market has been on a rollercoaster ride for the past few weeks as the sentiment has quickly shifted from post-election bullishness to being priced in for a slow-down or a recession.
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Fourth Quarter and Full Year 2024 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 High Growth International Stocks to Invest in Now
On January 15, Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company shared his outlook for 2025.
Ascendis Pharma A/S (NASDAQ:ASND) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Ascendis Pharma Third Quarter Earnings Call. At this time all participants are in a listen-only mode.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Ascendis Pharma A/S (NASDAQ:ASND) Q2 2024 Earnings Call Transcript
Operator: Hello. Thank you for standing by. Welcome to Ascendis Pharma's Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Ascendis Pharma A/S (ASND) Stock Soared on Unexpected Demand
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter.
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Q1 2024 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.